Michael E. Danielson
20Patents
8h-index
43Co-inventors
71Inventor score
Filing activity: Dec 18, 2003 → Dec 15, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7544697B2 | Pyrazolopyridines and analogs thereof | Chemistry; Metallurgy | 85 | Expired |
| US7091214B2 | Aryl substituted Imidazoquinolines | Human Necessities | 81 | Expired |
| US7598382B2 | Aryl substituted imidazoquinolines | Human Necessities | 77 | Expired |
| US7879849B2 | Pyrazolopyridines and analogs thereof | Chemistry; Metallurgy | 44 | Active |
| US7943609B2 | Chiral fused [1,2]imidazo[4,5-C] ring compounds | Chemistry; Metallurgy | 35 | Active |
| US8034938B2 | Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds | Chemistry; Metallurgy | 30 | Active |
| US8158794B2 | Hydroxyalkyl substituted imidazoquinoline compounds and methods | Human Necessities | 17 | Active |
| US8846710B2 | Method of preferentially inducing the biosynthesis of interferon | Emerging Cross-Sectional Technologies | 16 | Active |
| US8138173B2 | Pyrazolo[3,4-C]quinolines, pyrazolo[3,4-C]naphthyridines, analogs thereof, and methods | Human Necessities | 8 | Active |
| US8546383B2 | Chiral fused [1,2]imidazo[4,5-c] ring compounds | Chemistry; Metallurgy | 5 | Active |
| US10582723B2 | Yeast cell wall enriched in mannan oligosaccharide protein | Human Necessities | 2 | Active |
| US8350034B2 | Substituted chiral fused [1,2]imidazo[4,5-C] ring compounds | Chemistry; Metallurgy | 2 | Active |
| US9145410B2 | Pyrazolopyridines and analogs thereof | Chemistry; Metallurgy | 2 | Active |
| US9943607B2 | Beta-glucan compounds, compositions, and methods | Human Necessities | 2 | Active |
| US10114027B2 | Beta-glucan assay methods | Physics | 1 | Active |
| US11229701B2 | Methods for identifying beta-glucan binding to immune cells | Physics | 1 | Active |
| US10092646B2 | Compositions and methods for beta-glucan immunotherapy | Physics | 1 | Active |
| US9885726B2 | β-glucan assay methods | Physics | 1 | Active |
| US8835157B2 | Supported reagents, methods, and devices | Performing Operations; Transporting | 0 | Active |
| US12390526B2 | Methods for identifying beta-glucan binding to immune cells | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.